Omeros【OMER】銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

8.43

買値

8.02

売値

9.16

出来高

0.00 日の範囲 0.00

2.612 52 週間の範囲 13.60

時価総額

488.516M

前日終値

8.43

始値

時刻

8.02

最終取引時間

18:00:20

財務取引量

VWAP

平均取引量 (3 か月)

1,256,633

発行済株式数

57,949,760

配当利回り

PER

-4.15

1 株当たり利益 (EPS)

-2.03

歳入

純利益

-117.81M

Omeros Corp is a United States-based biopharmaceutical company. Its goal is to research, develop, and commercialize small-molecule and protein therapeutics targeting inflammation, coagulopathies, and disorders of the central nervous system. The company owns Omidria (phenylephrine and ketorolac injec... Omeros Corp is a United States-based biopharmaceutical company. Its goal is to research, develop, and commercialize small-molecule and protein therapeutics targeting inflammation, coagulopathies, and disorders of the central nervous system. The company owns Omidria (phenylephrine and ketorolac injection), approved by the U.S. Food and Drug Administration and launched in the U.S. for use during cataract surgery and intraocular lens replacement. Its product pipeline is focused on complement-associated thrombotic microangiopathies; complement-mediated glomerulonephropathies; Huntington's disease and cognitive impairment; and addictive and compulsive disorders. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.omeros.com

本社

Tumwater, Washington, USA

設立

Omeros Corporation is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker OMER. The last closing price for Omeros was US$8.43. Over the last year, Omeros shares have traded in a share price range of US$ 2.612 to US$ 13.60.

Omeros currently has 57,949,760 shares in issue. The market capitalisation of Omeros is US$488.52 million. Omeros has a price to earnings ratio (PE ratio) of -4.15.

Form 8-K - Current report

Omeros Announces Update on Statistical Analysis of Narsoplimab Pivotal Trial Primary Endpoint

– Newly Completed Sensitivity Analyses Demonstrate Robustness of Previously Announced Survival Superiority Over External Control in Patients with TA-TMA – Sensitivity analyses support the...

Form 8-K - Current report

Omeros’ Narsoplimab Meets its Pivotal Trial Primary Endpoint – Statistical Analysis Shows Survival Superiority Over External Control in Patients with TA-TMA

Primary statistical analysis of overall survival compared TA-TMA patients treated with narsoplimab in its pivotal trial to a cohort of over 100 TA-TMA patients not treated with narsoplimab in an...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.64	-7.05622932745	9.07	9.16	8.02	333138	8.71545485	CS
4	-2.44	-22.4471021159	10.87	11	8.02	531637	9.03217092	CS
12	4.14	96.5034965035	4.29	13.6	4.175	1256633	9.14650692	CS
26	4.04	92.0273348519	4.39	13.6	3.54	702431	8.06462126	CS
52	5.08	151.641791045	3.35	13.6	2.612	555146	6.59175027	CS
156	2.43	40.5	6	13.6	0.92	696978	4.61457587	CS
260	-4.46	-34.6004654771	12.89	25.49	0.92	772587	8.47936006	CS

OMER - Frequently Asked Questions (FAQ)

What is the current Omeros share price?

The current share price of Omeros is US$ 8.43

How many Omeros shares are in issue?

Omeros has 57,949,760 shares in issue

What is the market cap of Omeros?

The market capitalisation of Omeros is USD 488.52M

What is the 1 year trading range for Omeros share price?

Omeros has traded in the range of US$ 2.612 to US$ 13.60 during the past year

What is the PE ratio of Omeros?

The price to earnings ratio of Omeros is -4.15

What is the reporting currency for Omeros?

Omeros reports financial results in USD

What is the latest annual profit for Omeros?

The latest annual profit of Omeros is USD -117.81M

What is the registered address of Omeros?

The registered address for Omeros is 3400 CAPITOL BLVD SE, TUMWATER, WASHINGTON, 98501

What is the Omeros website address?

The website address for Omeros is www.omeros.com

Which industry sector does Omeros operate in?

Omeros operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
EVAXEvaxion Biotech AS	US$ 4.07 (69.58%)	15.39M
STISolidion Technology Inc	US$ 0.5629 (44.30%)	5.13M
PTIRGraniteShares 2X Long PLTR Daily ETF	US$ 215.33 (38.64%)	86.5k
PLTUDirexion DAily PLTR Bull 2X Shares	US$ 45.51 (37.95%)	122.16k
LITMSnow Lake Resources Ltd	US$ 0.893 (29.05%)	1.52M
UOKAMDJM Ltd	US$ 0.166 (-30.25%)	1.13M
UPCUniverse Pharmaceuticals Inc	US$ 0.3045 (-27.05%)	122.49k
TENXTenax Therapeutics Inc	US$ 4.48 (-24.71%)	98
EJHE Home Household Service Holdings Ltd	US$ 0.7921 (-22.34%)	49.16k
GNSSGenasys Inc	US$ 2.39 (-21.90%)	1
EVAXEvaxion Biotech AS	US$ 4.07 (69.58%)	15.39M
IVVDInvivyd Inc	US$ 1.22 (15.09%)	13M
STISolidion Technology Inc	US$ 0.5629 (44.30%)	5.13M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.1614 (-17.19%)	4.2M
BHATBlue Hat Interactive Entertainment Technology	US$ 0.0401 (-13.20%)	3.71M